Kavita V Dharmarajan, MD
img_Kavita V Dharmarajan
PROFESSOR | Radiation Oncology
PROFESSOR | Geriatrics and Palliative Medicine
Are you a patient?
Specialties
Hospital Medicine, Geriatrics, Palliative Care
New topic

Quality of life in radiation patients with cancer

Desc: Dr. Dharmarajan is investigating the benefits and role of radiation therapy in achieving disease control as well as improving pain and other cancer-related symptoms among patients with cancer of any type, and in particular patients living with metastatic cancers or multiple myeloma.

BA, University of Texas at Austin

MSc, London School of Economics and Political Science

MD, Columbia University College of Physicians & Surgeons

Residency, Pediatrics, Massachusetts General Hospital

Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center

Certifications

Radiation Oncology

2021

Paul B. Beeson Emerging Leaders Career Development Award in Aging

National Institute on Aging/National Institutes of Health

2020

Jeffrey H. Silverstein Memorial Award

American Geriatrics Society

2019

Butler Williams Scholar Program

National Institute on Aging

2018

Innovator Award

Association of Community Cancer Centers

2016

Junior Faculty Career Development Award

National Palliative Care Research Center

2015

Research Scholar Award

American Association of Hospice and Palliative Medicine

2013

Resident Research Award

Radiological Society of North America

2012

American Medical Association Foundation Seed Grant for Outstanding Young Investigators

American College of Radiation Oncology

2012

Research and Education Foundation Award

American Association for Women Radiologists

2012

Global Radiation Oncology Workforce Scholarship

American College of Radiation Oncology

2012

Annual Meeting Scientific Abstract Award

American Society for Radiation Oncology

2012

National Comprehensive Cancer Network Fellows’ Recognition Program

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Dharmarajan has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.